Results 21 to 30 of about 8,373 (188)

Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine.

, 1998
International audienceThe objective of this study was to evaluate the effects of ticlopidine on the generation of eicosanoids and nitric oxide in heart-transplant recipients.
Delaye, J., Boissonnat, P., Durbin, S., de Lorgeril, M., Bordet, J. C., Salen, P., Defreyn, G.   +6 more
core   +3 more sources

Antiplatelet Effect of Ticlopidine After Coronary Stenting [PDF]

, 1997
Objectives. This study sought to investigate the contribution of ticlopidine to the inhibition of platelet activation after coronary stent placement.Background.
Timm Dickfeld, Rudolf Blasini, Walter, Hanna, Anne Wehinger, Meinrad Gawaz, Dickfeld, Timm, Neumann, Franz-Josef, Gawaz, Meinrad, Blasini, Rudolf, Albert Schömig, Schömig, Albert, Wehinger, Anne, Hanna Walter, Franz-Josef Neumann   +13 more
core   +1 more source

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting

Frontiers in Neurology, 2019
Background and Purpose: Patients undergoing carotid artery stenting (CAS) who show low responsiveness to clopidogrel may have a higher risk of peri-procedural embolic events.
Jong-Won Chung, Suk Jae Kim, Jaechun Hwang, Mi Ji Lee, Jun Lee, Kyung-Yul Lee, Man-Seok Park, Sang Min Sung, Keon Ha Kim, Pyoung Jeon, Oh Young Bang   +10 more
doaj   +1 more source

Detecting Adverse Drug Events Through the Chronological Relationship Between the Medication Period and the Presence of Adverse Reactions From Electronic Medical Record Systems: Observational Study

JMIR Medical Informatics, 2021
BackgroundMedicines may cause various adverse reactions. An enormous amount of money and effort is spent investigating adverse drug events (ADEs) in clinical trials and postmarketing surveillance.
Kei Teramoto, Toshihiro Takeda, Naoki Mihara, Yoshie Shimai, Shirou Manabe, Shigeki Kuwata, Hiroshi Kondoh, Yasushi Matsumura   +7 more
doaj   +1 more source

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)

Jurnal Farmasi Sains dan Komunitas, 2017
Clopidogrel, an antithrombotic drug, has been proven by FDA as Plavix® was initially used for the prevention of vascular occlusive that cause of myocardial infarction, stroke, and vascular death in patients with atherosclerosis and then it is used to ...
Titien Siwi Hartayu, Dewi Setyaningsih
doaj   +1 more source

Kaposiform hemangioendothelioma: Diagnosis and treatment [PDF]

Pediatr Investig
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Tian Y, Tian Y, Wei L, Xu Z, Li L, Ma L.
europepmc   +2 more sources

The effect of antiaggregational therapy on the long-term patency of the femoropopliteal/crural bypass [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2012
Introduction. Antiaggregational therapy can reduce thrombosis development following the arterial reconstruction surgery. In most cases acetylsalicylic acid and ticlopidine are used as antiaggregational agents. Objective.
Vasić Dragan, Radmili Oliver, Davidović Lazar, Vraneš Milica   +3 more
doaj   +1 more source

Clopidogrel versus ticlopidine after intracoronary stent placement [PDF]

, 1999
OBJECTIVESThe study compared the safety and efficacy of ticlopidine with clopidogrel in patients receiving coronary stents.BACKGROUNDStent thrombosis is reduced when ticlopidine is administered with aspirin.
Malcolm R Bell, David R Holmes, Rihal, Charanjit S, Peter B Berger, Henry Ting, Garratt, Kirk, Charanjit S Rihal, Ting, Henry, Bellot, Victoria, Steve Melby, Victoria Bellot, LaVon Hammes, Diane Grill, Bell, Malcolm R, Melby, Steve, Berger, Peter B, Mathew, Verghese, Barsness, Gregory, Gregory Barsness, Holmes, David R, Grill, Diane, Kirk Garratt, Hammes, LaVon, Verghese Mathew   +23 more
core   +1 more source

Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature

Italian Journal of Medicine, 2012
Introduction Cholestatic hepatitis is frequently a drug-related syndrome. We describe the case of a 57-year-old man who developed cholestatic hepatitis two months after starting therapy with ticlopidine following a carotid endarterectomy.Materials and ...
Luigi Anastasio, Valerio Manno, Maria Carbone, Nicola Lentini, Sandro Baldari, Lucia Sofia, Giuseppe Topa, Antonio Arone   +7 more
doaj   +1 more source

Study of Factors to Increase the Usage Rate of Generic Drugs in Platelet Aggregation Inhibitors

Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2023
To reduce pharmacy-related medical expenses, it is necessary to reduce drug costs. One way to achieve this is by increasing the usage rate of generic drugs.
Takaaki Suzuki BS, Mari Iwata BS, Mika Maezawa MS, Kiyoka Matsumoto BS, Mizuki Tanaka BS, Riko Satake BS, Misaki Inoue BS, Yu Yoshida BS, Kazuhiro Iguchi PhD, Mitsuhiro Nakamura PhD   +9 more
doaj   +1 more source